FICO enters its July 31 print riding a 12% weekly surge to $1,373 — momentum that has materially changed the setup from the bearish backdrop described in last week's preview, and now asks whether the rally has staying power.
Options traders are leaning more defensive than they were a week ago. The put/call ratio has climbed to 0.89, around 1.5 standard deviations above its 20-day mean of 0.83 — a mild but noticeable shift toward downside protection that tracks the stock's sharp run-up. With FICO having gained 16% over the past month, hedging into the print is the rational response. That said, the reading remains well inside the 52-week high of 1.10, so the options market is pricing caution, not alarm.
Short interest tells a more nuanced story. Bears have added modestly back to their positions — SI ticked up roughly 3% on the week to 9.3% of the free float, partially reversing the month-long retreat flagged in prior notes. That rebuild is notable after the stock's post-July 29 surge, but the borrow market does not suggest conviction: availability holds at 304%, meaning the lending pool carries roughly three shares available for every one already borrowed, and cost to borrow remains a negligible 0.52%. Short sellers are not under pressure, and there is ample room to press or cover without friction.
The analyst community is broadly constructive but not uniformly so, and the gap between the bullish and neutral camps is wide. Needham holds a $1,650 Buy target while UBS, which raised its target to $1,270 in early July, remains Neutral. Jefferies and Wells Fargo both carry Buy ratings but trimmed targets earlier in the year, reflecting an open debate about whether FICO's pricing power in credit scoring can offset any softening in lending volumes. Bulls cite the structural dominance of the Scores franchise and management's $1.5 billion term loan and buyback program as signals of confidence; bears point to the concentration risk in a Scores business tied to mortgage and lending cycles that could compress if economic conditions deteriorate. The consensus mean target of $1,535 sits about 12% above the current price — a modest implied return that reflects the Street's divided conviction rather than a ringing endorsement.
The print will test whether the operational momentum from the July 29 report — which launched the stock's 9% post-earnings run — extends into the current quarter's numbers, or whether the rapid 16% one-month recovery has already priced in the good news.
See the live data behind this article on ORTEX.
Open FICO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
